These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Generic Pharmaceutical Industry Association Orphan Drug Institute. Haddad W Prog Clin Biol Res; 1985; 197():41-5. PubMed ID: 4070298 [No Abstract] [Full Text] [Related]
3. When drugs are in short supply. Zurlinden J Nurs Spectr (Wash D C); 1999 Feb; 9(4):15-6. PubMed ID: 10542818 [No Abstract] [Full Text] [Related]
4. [Increased significance of adverse effects of drugs--a threat to the industry]. Werkö L Lakartidningen; 2004 Dec; 101(50):4134-6. PubMed ID: 15631270 [No Abstract] [Full Text] [Related]
5. Orphan drug development in the United States. Groft SC CPJ; 1985 May; 118(5):219-22. PubMed ID: 10271306 [TBL] [Abstract][Full Text] [Related]
6. The development of orphan drugs--a pharmaceutical company perspective. Stucki JC Prog Clin Biol Res; 1985; 197():95-104. PubMed ID: 4070303 [No Abstract] [Full Text] [Related]
7. Orphan drug development across Europe: bottlenecks and opportunities. Heemstra HE; de Vrueh RL; van Weely S; Büller HA; Leufkens HG Drug Discov Today; 2008 Aug; 13(15-16):670-6. PubMed ID: 18583178 [TBL] [Abstract][Full Text] [Related]
8. Studies involving orphan products for treating/diagnosing women's diseases. Haffner ME Food Drug Law J; 1993; 48(2):205-11. PubMed ID: 11653144 [No Abstract] [Full Text] [Related]
9. [Orphan drugs from the perspective of research-based pharmaceutical and biotech companies]. Sydow S; Throm S Internist (Berl); 2019 Apr; 60(4):405-410. PubMed ID: 30859276 [No Abstract] [Full Text] [Related]
10. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
11. The Pharmaceutical Manufacturers Association Commission on Drugs for Rare Diseases. Goldstein GS Prog Clin Biol Res; 1985; 197():35-9. PubMed ID: 4070297 [No Abstract] [Full Text] [Related]
12. Orphan Drug Act on congressional agenda. von Oehsen WH Physician Exec; 1989; 15(3):34-5. PubMed ID: 10313123 [TBL] [Abstract][Full Text] [Related]
13. Orphan Drugs Information Center. FDA Drug Bull; 1985 Apr; 15(1):9-10. PubMed ID: 3996806 [No Abstract] [Full Text] [Related]
14. Orphan drugs. Improved medical treatment of rare diseases. Cramer R Ala J Med Sci; 1988 Jul; 25(3):257-67. PubMed ID: 3052135 [No Abstract] [Full Text] [Related]
17. Orphan drugs: the question of products liability. Scharf SF Am J Law Med; 1985; 10(4):491-513. PubMed ID: 3911776 [TBL] [Abstract][Full Text] [Related]
18. [Orphan drugs: what are they and why do they not find adoptive parents?]. Lechat P Therapie; 1987; 42(1):33-6. PubMed ID: 3590064 [No Abstract] [Full Text] [Related]
19. [Orphan drugs--competing for a better name in Sweden]. Karlsson Y Lakartidningen; 1990 Feb; 87(9):658. PubMed ID: 2308437 [No Abstract] [Full Text] [Related]
20. Problems associated with developing orphan drugs into available therapy. Van Woert MH Prog Clin Biol Res; 1985; 197():171-3. PubMed ID: 4070291 [No Abstract] [Full Text] [Related] [Next] [New Search]